Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis

Nephrology

Volumn 13, Issue 2, 2008, Pages 104-108

  Naganuma, Toshihide ^a   Sugimura, Kazunobu ^a   Uchida, Junji ^a   Tashiro, Koichiro ^a   Yoshimura, Rikio ^a   Takemoto, Yoshiaki ^a   Nakatani, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dialysis related amyloidosis; Haemodialysis; Matrix metalloproteinase 3

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; STROMELYSIN;

ADULT; ARTICLE; BONE CYST; CARPAL TUNNEL SYNDROME; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY AMYLOIDOSIS; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SHOULDER PAIN; SPONDYLOARTHROPATHY; SYNOVIUM;

AGED; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 38949212481     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00845.x     Document Type: Article

References (16)

1. Chambers TJ, Darby JA, Fuller K. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res. 1985 241 : 671 5.
2. Everts V, Delaisse JM, Korper W, Niehof A, Vaes G, Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J. Cell Physiol. 1992 150 : 221 31.
3. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N. Engl. J. Med. 1990 322 : 1277 89.
4. Maeda S, Sawai T, Uzuki M et al. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann. Rheum. Dis. 1995 54 : 970 75.
5. Yamanaka H, Matsuda Y, Tanaka M et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum. 2000 43 : 852 8.
6. Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J. Biol. Chem. 1986 261 : 14245 55.
7. Okada Y, Konomi H, Yada T, Kimata K, Nagase H. Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett. 1989 244 : 473 6.
8. Xie DL, Hui F, Meyers R, Homandberg GA. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: Stromelysin plays a major role in chondrolysis. Arch. Biochem. Biophys. 1994 311 : 205 12.
9. Ito A, Nagase H. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch. Biochem. Biophys. 1988 267 : 211 16.
10. Van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int. 1991 39 : 1012 19.
11. Nagoshi M, Hashizume H, Konishiike T, Kawai A, Inoue H. Hemodialysis-related subacromial lesion: Diagnostic imaging and minimally invasive treatment. Clin. Nephrol. 2000 54 : 112 20.
12. Kuntz D, Marie P, Naveau B, Maziere B, Tubiana M, Ryckewaert A. Extended treatment of primary osteoporosis by sodium fluoride combined with 25 hydroxycholecalciferol. Clin. Rheumatol. 1984 3 : 145 53.
13. Preston GA, Barrett CV, Alcorta DA et al. Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels. Nephron 2002 92 : 817 23.
14. Ishizaki M, Matsunaga T, Adachi K, Miyashita E. Serum matrix metalloproteinase-3 in hemodialysis patients with dialysis-related amyloidosis. Hemodial. Int. 2004 8 : 219 25.
15. Jadoul M, Garbar C, Noel H et al. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: A prospective post-mortem study. Kidney Int. 1997 51 : 1928 32.
16. Migita K, Eguchi K, Tominaga M, Origuchi T, Kawabe Y, Nagataki S. Beta 2-microglobulin induces stromelysin production by human synovial fibroblasts. Biochem. Biophys. Res. Commun. 1997 239 : 621 5.